Home » Newsletters » BioWorld Science

BioWorld Science

April 24, 1998

View Archived Issues

Maximum androgen blockade is superior to orchiectomy in prostate cancer

Danaparoid sodium is not beneficial for acute ischemic stroke

Novartis R&D pipeline in review

SomatoKine effectively prevents of muscular atrophy

Bristol-Myers Squibb: Q1 1998 highlights

Company Profile: Pangaea

GeneMedicine reports advances in muscle gene delivery systems

Nippon Kayaku discloses new antiproliferative compound produced by bacterial species

GnRH antagonists for sex hormone-related disorders described by Takeda

Targeted Genetics patents retroviral gene delivery system using chimeric proteins

Novel flavone and flavanone compounds for ulcers, IBD

Study finds diuretics with beta-blockers to be most efficient in lowering blood pressure

Cytokine Networks to initiate clinical trial of anticancer vaccine

PRO-542 demonstrates potent antiviral activity

Positive phase III results reported for Neurobloc in cervical dystonia

Nihon Nohyaku's ACAT inhibitor tested in SHRSP

FDA advisory committee will meet to discuss Lyme disease and cholera vaccines

Novopharm seeks FDA approval to begin phase Ib/II trials with GPI-2A

CP-060S: a cardioprotective agent with a novel mechanism of action

Kyowa Hakko develops new antitumor agents from DC-89

AChE inhibitors for Alzheimer's disease disclosed by Sagami

Ono presents new iNOS inhibitors

Chemokine receptor antagonists developed at Banyu

ArQule and Acadia forge drug discovery collaboration

Hyal discovery may enable better detection of breast cancer

Immunosuppressive MDR inhibitor isolated from bacterial species

New prokinetic agent emerges from the pipeline at Zeria

Abbott's vitamin D analogue approved for secondary hyperparathyroidism

Milkhaus granted patent for scar treatment agent

OHM-3507: a fentanyl derivative with incongruent pharmacological effects

BioFocus, Scriptgen collaborate on lead optimization of new antivirals

New antiglaucoma agent approved in U.S.